Supernus Pharmaceuticals (SUPN) Q3 2022 Earnings

4AugConfirmed
Q3 2021
Q4 2021
Q2 2022
Q3 2022
0.04
0.17
0.3
0.43

Details

Expected EPS
0.33
Actual EPS
0.14
Surprise EPS
-0.19
Surprise Percent
+57.58%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.14 per share for Q3 2022.

0 Comments

Share your thoughts